P. Rasmussen

Peripheral markers of brain damage and blood-brain barrier dysfunction.

M. Cavaglià, A. Kanner, M. Mayberg, 2003, Restorative neurology and neuroscience.

Serum Transthyretin Monomer as a Possible Marker of Blood-to-CSF Barrier Disruption

G. Barnett, M. Mayberg, D. Janigro, 2003, The Journal of Neuroscience.

Multimodal investigations of trans-endothelial cell trafficking under condition of disrupted blood-brain barrier integrity

D. Janigro, Q. Teng, T. Masaryk, 2010, BMC Neuroscience.

Cyclosporine A, FK506, and NIM811 ameliorate prolonged CBF reduction and impaired neurovascular coupling after cortical spreading depression

M. Lauritzen, H. Piilgaard, B. M. Witgen, 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Serum S-100β as a possible marker of blood–brain barrier disruption

J Perl, G. Barnett, M. Mayberg, 2002, Brain Research.

Intracellular and circulating neuronal antinuclear antibodies in human epilepsy

D. Janigro, A. Alexopoulos, C. Ghosh, 2013, Neurobiology of Disease.

Serum S-100beta as a possible marker of blood-brain barrier disruption.

J Perl, G. Barnett, M. Mayberg, 2002, Brain research.

Blood–brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity

D. Janigro, Q. Teng, N. Marchi, 2010, Brain Research.

A pro-convulsive carbamazepine metabolite: Quinolinic acid in drug resistant epileptic human brain

J. González-Martínez, D. Janigro, Hu Yang, 2012, Neurobiology of Disease.